+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vivus - logo

VIVUS is a biopharmaceutical company that develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company’s lead product Qsymia is a combination appetite suppressant/stimulant and seizure medication indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in overweight and obese adults. VIVUS was founded in 1991 and is headquartered in Campbell, California.

From
Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • February 2017
  • 91 pages
From
Global Anti-obesity Drugs Market 2021-2025 - Product Thumbnail Image

Global Anti-obesity Drugs Market 2021-2025

  • Report
  • March 2021
  • 120 pages
From
From
From
From
From
From
From
From
From
Qsymia 2020 U.S. Promotional Audit Report - Product Thumbnail Image

Qsymia 2020 U.S. Promotional Audit Report

  • Report
  • July 2021
  • 28 pages
From
Obesity - Pipeline Review, H2 2020 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 640 pages
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • October 2016
  • 223 Pages
From
Loading Indicator
adroll